Previous Article | Next Article 
Journal of Virology, September 2001, p. 8761-8771, Vol. 75, No. 18
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.18.8761-8771.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Latency-Associated Nuclear Antigen Encoded by Kaposi's
Sarcoma-Associated Herpesvirus Interacts with Tat and Activates the
Long Terminal Repeat of Human Immunodeficiency Virus Type 1 in
Human Cells
Teresa S.
Hyun,1,2
Chitra
Subramanian,3
Murray A.
Cotter II,1,2
Robert A.
Thomas,4 and
Erle S.
Robertson1,2,3,*
Cellular and Molecular Biology Graduate
Program,1 Medical Scientist Training
Program,2 and Department of
Microbiology and Immunology,3 University of
Michigan Medical School, Ann Arbor, Michigan 48109-0934, and
Department of Pediatrics, Children's Research Center of
Michigan, Wayne State University, Detroit, Michigan
482024
Received 21 May 2001/Accepted 5 June 2001
The latency-associated nuclear antigen (LANA) is constitutively
expressed in cells infected with the Kaposi's sarcoma (KS) herpesvirus
(KSHV), also referred to as human herpesvirus 8. KSHV is tightly
associated with body cavity-based lymphomas (BCBLs) in
immunocompromised patients infected with human immunodeficiency virus
(HIV). LANA, encoded by open reading frame 73 of KSHV, is one of a
small subset of proteins expressed during latent infection and was
shown to be important in tethering the viral episome to host
chromosomes. Additionally, it has been shown that LANA can function as
a regulator of transcription. However, its role in the progression of
disease is still being elucidated. Since KS is one of the most common
AIDS-associated cancers in the United States and BCBLs appear
predominantly in AIDS patients, we examined whether LANA is able to
regulate the HIV type 1 (HIV-1) long terminal repeat (LTR). Using
luciferase-based transient transfection assays, we found that LANA was
able to transactivate the HIV-1 LTR in the human B-cell line BJAB,
human monocytic cell line U937, and the human embryonic kidney
fibroblast cell line 293T. Moreover, we observed that the virus-encoded
HIV transactivator protein Tat cooperated with LANA in activation of
the LTR in a dose-response fashion with increasing amounts of LANA.
Surprisingly, LANA alone was sufficient to transactivate the HIV-1 LTR
in BJAB cells. In similar assays using a HIV-1 LTR construct with the
core enhancer elements deleted; the activity of LANA was diminished but
not abolished, indicating a mechanism which involves the cooperation of
the core enhancer elements and downstream elements which include Tat. Furthermore, transient transfection of an infectious clone of HIV
with LANA demonstrated effects similar to those seen in the reporter
assays based on Western blot analysis of HIV Gag polypeptide p24.
Interestingly, we also demonstrated that the carboxy terminus of LANA
associates with Tat in cells and in vitro. These experiments suggest a
role for LANA in activating the HIV-1 LTR through association with
cellular molecules targeting the core enhancer elements and Tat and may
have important consequences in increasing the levels of HIV in infected
individuals and, hence, the disease state.
*
Corresponding author. Mailing address: Comprehensive
Cancer and Geriatric Center, 3217 CCGC Bldg., University of Michigan Medical School, Ann Arbor, MI 48109-0934. Phone: (734) 647-7296. Fax:
(734) 764-3562. E-mail: esrobert{at}umich.edu.
Journal of Virology, September 2001, p. 8761-8771, Vol. 75, No. 18
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.18.8761-8771.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wen, K. W., Dittmer, D. P., Damania, B.
(2009). Disruption of LANA in Rhesus Rhadinovirus Generates a Highly Lytic Recombinant Virus. J. Virol.
83: 9786-9802
[Abstract]
[Full Text]
-
Rossetto, C., Yamboliev, I., Pari, G. S.
(2009). Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 K-bZIP Modulates Latency-Associated Nuclear Protein-Mediated Suppression of Lytic Origin-Dependent DNA Synthesis. J. Virol.
83: 8492-8501
[Abstract]
[Full Text]
-
Lan, K., Choudhuri, T., Murakami, M., Kuppers, D. A., Robertson, E. S.
(2006). Intracellular Activated Notch1 Is Critical for Proliferation of Kaposi's Sarcoma-Associated Herpesvirus-Associated B-Lymphoma Cell Lines In Vitro.. J. Virol.
80: 6411-6419
[Abstract]
[Full Text]
-
Si, H., Robertson, E. S.
(2006). Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Induces Chromosomal Instability through Inhibition of p53 Function. J. Virol.
80: 697-709
[Abstract]
[Full Text]
-
Caselli, E., Galvan, M., Cassai, E., Caruso, A., Sighinolfi, L., Di Luca, D.
(2005). Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells. Blood
106: 2790-2797
[Abstract]
[Full Text]
-
Lan, K., Kuppers, D. A., Verma, S. C., Sharma, N., Murakami, M., Robertson, E. S.
(2005). Induction of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen by the Lytic Transactivator RTA: a Novel Mechanism for Establishment of Latency. J. Virol.
79: 7453-7465
[Abstract]
[Full Text]
-
Lan, K., Kuppers, D. A., Robertson, E. S.
(2005). Kaposi's Sarcoma-Associated Herpesvirus Reactivation Is Regulated by Interaction of Latency-Associated Nuclear Antigen with Recombination Signal Sequence-Binding Protein J{kappa}, the Major Downstream Effector of the Notch Signaling Pathway. J. Virol.
79: 3468-3478
[Abstract]
[Full Text]
-
An, F.-Q., Compitello, N., Horwitz, E., Sramkoski, M., Knudsen, E. S., Renne, R.
(2005). The Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Modulates Cellular Gene Expression and Protects Lymphoid Cells from p16 INK4A-induced Cell Cycle Arrest. J. Biol. Chem.
280: 3862-3874
[Abstract]
[Full Text]
-
Ye, F.-C., Zhou, F.-C., Yoo, S. M., Xie, J.-P., Browning, P. J., Gao, S.-J.
(2004). Disruption of Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen Leads to Abortive Episome Persistence. J. Virol.
78: 11121-11129
[Abstract]
[Full Text]
-
Verma, S. C., Borah, S., Robertson, E. S.
(2004). Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Up-Regulates Transcription of Human Telomerase Reverse Transcriptase Promoter through Interaction with Transcription Factor Sp1. J. Virol.
78: 10348-10359
[Abstract]
[Full Text]
-
Lim, C., Choi, C., Choe, J.
(2004). Mitotic Chromosome-Binding Activity of Latency-Associated Nuclear Antigen 1 Is Required for DNA Replication from Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus. J. Virol.
78: 7248-7256
[Abstract]
[Full Text]
-
Lan, K., Kuppers, D. A., Verma, S. C., Robertson, E. S.
(2004). Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Inhibits Lytic Replication by Targeting Rta: a Potential Mechanism for Virus-Mediated Control of Latency. J. Virol.
78: 6585-6594
[Abstract]
[Full Text]
-
Lim, C., Seo, T., Jung, J., Choe, J.
(2004). Identification of a virus trans-acting regulatory element on the latent DNA replication of Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol.
85: 843-855
[Abstract]
[Full Text]
-
Verma, S. C., Robertson, E. S.
(2003). ORF73 of Herpesvirus Saimiri Strain C488 Tethers the Viral Genome to Metaphase Chromosomes and Binds to cis-Acting DNA Sequences in the Terminal Repeats. J. Virol.
77: 12494-12506
[Abstract]
[Full Text]
-
Moorman, N. J., Willer, D. O., Speck, S. H.
(2003). The Gammaherpesvirus 68 Latency-Associated Nuclear Antigen Homolog Is Critical for the Establishment of Splenic Latency. J. Virol.
77: 10295-10303
[Abstract]
[Full Text]
-
Pan, H.-Y., Zhang, Y.-J., Wang, X.-P., Deng, J.-H., Zhou, F.-C., Gao, S.-J.
(2003). Identification of a Novel Cellular Transcriptional Repressor Interacting with the Latent Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus. J. Virol.
77: 9758-9768
[Abstract]
[Full Text]
-
Dourmishev, L. A., Dourmishev, A. L., Palmeri, D., Schwartz, R. A., Lukac, D. M.
(2003). Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis. Microbiol. Mol. Biol. Rev.
67: 175-212
[Abstract]
[Full Text]
-
Schafer, A., Lengenfelder, D., Grillhosl, C., Wieser, C., Fleckenstein, B., Ensser, A.
(2003). The Latency-Associated Nuclear Antigen Homolog of Herpesvirus Saimiri Inhibits Lytic Virus Replication. J. Virol.
77: 5911-5925
[Abstract]
[Full Text]
-
Caselli, E., Galvan, M., Santoni, F., Rotola, A., Caruso, A., Cassai, E., Luca, D. D.
(2003). Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection. J. Gen. Virol.
84: 1123-1131
[Abstract]
[Full Text]
-
Lim, C., Lee, D., Seo, T., Choi, C., Choe, J.
(2003). Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Functionally Interacts with Heterochromatin Protein 1. J. Biol. Chem.
278: 7397-7405
[Abstract]
[Full Text]
-
Hu, J., Garber, A. C., Renne, R.
(2002). The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Supports Latent DNA Replication in Dividing Cells. J. Virol.
76: 11677-11687
[Abstract]
[Full Text]
-
Lim, C., Sohn, H., Lee, D., Gwack, Y., Choe, J.
(2002). Functional Dissection of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Involved in Latent DNA Replication and Transcription of Terminal Repeats of the Viral Genome. J. Virol.
76: 10320-10331
[Abstract]
[Full Text]